Anti-inflammatory treatment for dermatological disorders.

Trial Summary: A Phase I, randomised, double blind, placebo-controlled, study of the safety, tolerability, pharmacokinetics and clinical activity of AKP-11 administration to healthy volunteers and patients with mild to moderate psoriasis.
Recruitment Status: Not yet recruiting
Focus of the trial: Treatment
Phase of the trial: Phase 1
Ethics Approval: No
Location of trial: 3004 - Melbourne

-- Contact --
Name: Dr Jason Lickliter
Address: Nucleus Network Ltd, Level 5, 89 Commercial Road, Melbourne VIC 3004

Country: Australia
Phone: 1800 243 733
Fax: +613 9076 8911
Email: j.lickliter@nucleusnetwork.com.au